Biography

Dr. Adkins earned Bachelor of Science degrees in Biomedical Science and Biological Science at Marshall University. He attended medical school at the Joan C. Edwards School of Medicine at Marshall University, and completed his Anatomic Pathology/Clinical Pathology residency at Vanderbilt University Medical Center. He went on to complete fellowship training in Blood Banking/Transfusion Medicine and Hematopathology at University of Virginia Health. He is board-certified in Anatomic Pathology and Clinical Pathology with subspecialty certification in Blood Banking/Transfusion Medicine and Hematopathology. 

His interests include resident and fellow education as well as clinical research. 

Education

Medical School
Marshall University (2015)
Residency
Vanderbilt University Medical Center (2019), Pathology/lab Medicine
Fellowship
University of Virginia (2020), Hematopathology
Fellowship
University of Virginia (2021), Blood Banking/transfusion Medicine

Publications

Featured Publications LegendFeatured Publications

Therapeutic plasma exchange as an intervention for gemtuzumab ozogamicin impaired hemoglobin scavenging: A case and systematic review.
Adkins BD, Noland DK, Slone T, Sadanand A, J Clin Apher 2024 Jun 39 3 e22116
Industry Payments to American Society of Hematology Clinical Practice Guideline Authors.
Jacobs JW, Booth GS, Stephens LD, Adkins BD, Martin AA, Lundberg GD, Glover RT, Khan SS, Silver JK, Woo JS, Blood Adv 2024 Apr
Gender differences in scholarly productivity of early-career transfusion medicine physicians.
Ipe TS, Tanhehco YC, Booth GS, Adkins BD, Vox Sang 2024 Mar
Analysis of editor in chief gender and associated journal variables among 126 pathology journals.
Wang DK, Clark LM, Stephens LD, Adkins BD, Khan SS, Booth GS, Jacobs JW, Am J Clin Pathol 2024 Mar
Gender composition and geographical representation of American Society of Hematology clinical practice guideline authors.
Jacobs JW, Martin AA, Stephens LD, Adkins BD, Woo JS, Sharma D, Wheeler AP, Glover RT, Yui JC, Walker SC, Khan SS, Booth GS, Silver JK, Lancet Haematol 2024 Mar 11 3 e182-e183
Crizanlizumab and sickle cell disease: When should medications have their approval status revoked?
Jacobs JW, Stephens LD, Chooljian DM, Sharma D, Adkins BD, Booth GS, Am J Hematol 2024 Feb
Commentary on A Differential Diagnosis of Thrombotic Microangiopathy in a 7-Year-Old Girl.
Adkins BD, Luu HS, Clin Chem 2024 Feb 70 2 372
Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic review.
Jacobs JW, Sharma D, Stephens LD, Figueroa Villalba CA, Rinder HM, Woo JS, Wheeler AP, Gerberi D, Goel R, Tormey CA, Booth GS, Bloch EM, Adkins BD, Br J Haematol 2024 Jan
New threats from an old foe: Evaluating the risk to the blood supply due to increasing incidence and endemicity of leprosy in the United States.
Jacobs JW, Adkins BD, Bibb LA, Stephens LD, Woo JS, Bloch EM, Booth GS, Transfus Apher Sci 2024 Jan 103877
Gender versus sex: recognizing and adhering to established guidelines for diversity, equity, and inclusion research.
Jacobs JW, Booth GS, Wheeler AP, Sharma D, Walker SC, Adkins BD, Woo JS, Acad Pathol 2024 11 1 100104